EFTRW लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:36):
Our systems believe the stock currently is undervalued by 0.94% compare to its pairs and should correct upwards.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
आज की मात्रा	97 702
औसत मात्रा	0
बाजार मूल्य	641 019
EPS	$-2.16 ( Q1 \| 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.92%

ABCL 2.01%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.93%

ABSI 3.06%

ABUS -2.62%

ABVX -3.53%

ACAD -0.80%

ACER -17.95%

ACET -3.74%

ACGN 1.29%

ACHL -4.15%

ACHV -1.73%

ACIU -0.50%

ACLX -0.20%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.77%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.30%

ADTX -3.47%

ADVM -3.04%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -2.10%

AGEN -0.81%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.28%

AKRO -2.56%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.41%

ALEC -4.13%

ALGS -2.41%

ALKS -0.23%

ALLK -8.90%

ALLO -6.67%

ALLR -4.23%

ALNA 3.16%

ALNY 1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.05%

ALVR 0.93%

ALXN 0.00%

ALXO -10.94%

ALZN 5.07%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.44%

ANPC -3.15%

APGE -1.07%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.10%

APLT -4.16%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.88%

ARDS -14.23%

ARDX -0.91%

ARGX -0.93%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.95%

ARWR -1.68%

ASLN -3.21%

ASMB -3.70%

ASND -1.27%

ATAI -1.11%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 5.34%

ATRA -2.49%

ATXI 1.93%

ATXS -1.05%

AUPH -1.17%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.43%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.76%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.94%

BCAB 2.61%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.48%

BCTX 8.67%

BCTXW -21.88%

BCYC 0.64%

BDRX -6.00%

BDTX -0.85%

BEAM 0.02%

BFRA -2.91%

BGNE -2.19%

BIOR -1.72%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.41%

BMEA -9.65%

BMRN 0.38%

BNOX -2.22%

BNTC -2.11%

BNTX -1.11%

BOLD -8.80%

BOLT -0.22%

BPMC -1.34%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 26.27%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.90%

CADL -0.53%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.85%

CARM 12.23%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.99%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.43%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.78%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.62%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.47%

CINC 0.00%

CING 0.67%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.63%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.63%

CMPI 0.00%

CMPX -10.74%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.62%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.49%

CORT 2.01%

COYA -1.46%

CPRX -0.40%

CRBP -2.10%

CRBU -4.56%

CRDF -2.21%

CRGX 1.34%

CRIS -0.38%

CRNX -5.93%

CRSP 1.06%

CRTX 2.63%

CRVO -2.54%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -3.66%

CTXR 1.30%

CUE 3.61%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 8.81%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.52%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 30.43%

DNLI -1.97%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.81%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.41%

EDSA -1.00%

EFTR 7.54%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.39%

ELOX 7.69%

ELTX -0.88%

ELVN -4.59%

ELYM 0.56%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.93%

ENTA -0.24%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.45%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.23%

EXAI -0.44%

EXEL -0.16%

EYEG -0.69%

EYEN 1.55%

EYPT 0.12%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -18.11%

FBRX -0.04%

FDMT -4.59%

FENC -1.29%

FGEN -5.12%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.38%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.71%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.49%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.43%

GHRS -2.85%

GLMD 0.31%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.09%

GMAB -0.53%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.98%

GNTA 3.94%

GOSS -7.81%

GOVX 3.19%

GOVXW -49.04%

GPCR -7.20%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.14%

GRTX 0.00%

GTHX 0.00%

GUTS -5.31%

GXGXW 41.67%

GYRE -6.02%

HALO -0.76%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.56%

HRMY 1.10%

HRTX 1.64%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.99%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.46%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.58%

IMMX -7.76%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.75%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.50%

INAB 0.59%

INBX 0.47%

INCY -0.73%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.80%

INO -1.95%

INSM -0.66%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS -0.22%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -3.15%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -4.13%

JAGX 0.28%

JANX -4.08%

JAZZ -0.57%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -9.25%

KRTX 0.03%

KRYS -0.86%

KTRA 15.95%

KTTA 8.16%

KTTAW 0.92%

KURA -1.66%

KYMR -2.05%

KYTX -3.62%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.08%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.07%

LENZ -4.03%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -8.78%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -5.03%

LPTX -1.65%

LQDA -0.24%

LRMR -1.78%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.86%

LXRX -2.06%

LYEL -35.45%

LYRA 2.83%

MACK 0.10%

MBIO -8.94%

MBRX -2.86%

MCRB 1.12%

MDGL -2.55%

MDNA -13.16%

MDWD 0.10%

MDXG -2.50%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.11%

MLYS -5.67%

MNKD -1.14%

MNMD 0.07%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.34%

MREO -4.15%

MRKR 2.68%

MRNA -4.72%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.30%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 8.38%

NAMS 1.73%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.93%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.88%

NLSPW 26.67%

NMRA -0.74%

NMTR -42.97%

NOVN -24.84%

NRBO 11.36%

NRIX -1.11%

NRSN -3.63%

NRSNW 0.00%

NRXP -6.69%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.26%

NTRBW -31.07%

NUVL -1.97%

NVAX -1.14%

NVCT 3.94%

NVIV -34.28%

NXTC -3.24%

NYMX -0.05%

OABI 0.33%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -1.98%

OCUP 1.64%

ODT -4.27%

OKYO 1.51%

OLMA -5.61%

OMER -0.77%

OMGA 6.28%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -0.33%

ORGS -4.26%

ORIC -3.41%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -7.29%

PBYI 1.01%

PCSA 0.00%

PCVX -0.23%

PDSB -0.95%

PEPG 1.55%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -4.96%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.64%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.60%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.36%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.31%

PTE -0.82%

PTGX -1.55%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 4.43%

QLGN -3.72%

QNCX 5.67%

QNRX 0.37%

QSI -11.66%

QSIAW -3.13%

QTTB -4.51%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 1.23%

RCKT -8.09%

REGN -0.72%

RENB -3.11%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -0.47%

REVBU 3.46%

REVBW 4.38%

RGLS -4.72%

RGNX -5.28%

RIGL -3.29%

RLAY -4.60%

RLMD 0.33%

RLYB 1.01%

RNA -0.41%

RNAC -5.65%

RNAZ -0.11%

RNXT 1.88%

ROIV -2.03%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.13%

RVMDW -30.00%

RVNC 1.91%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.47%

RYTM -5.92%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -3.78%

SAVA -0.41%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -1.01%

SCPS 0.00%

SEEL -4.09%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.05%

SGMT -0.96%

SGTX -2.56%

SIOX 22.63%

SLDB -4.40%

SLGL 4.00%

SLN -4.21%

SLNO -2.58%

SLRX 5.91%

SLS -3.00%

SMMT -2.50%

SNDX 0.61%

SNGX -3.02%

SNPX -3.23%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -31.19%

SRPT -1.01%

SRRA 0.00%

SRRK -2.29%

SRZN -2.45%

STAB 0.00%

STOK -5.21%

STRO -3.01%

STSA 0.00%

STTK -4.64%

SURF -0.93%

SVRA -3.29%

SWTX 0.11%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.19%

TARS -0.08%

TBPH 0.36%

TCBP 0.00%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.68%

TECH -0.08%

TENX -1.27%

TERN -6.34%

TFFP -3.05%

TGTX -3.00%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.59%

TNXP -5.34%

TNYA -8.58%

TPST 2.52%

TRDA -3.86%

TRVI 0.77%

TRVN 5.02%

TSHA -24.44%

TSVT -2.40%

TTNP -9.27%

TVTX 0.25%

TYRA -8.18%

UBX -0.96%

UNCY -3.39%

URGN -1.96%

UTHR -0.45%

VACC 11.36%

VALN -2.89%

VAXX 77.82%

VBIV -0.45%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.14%

VERA -2.77%

VERU 0.72%

VERV -2.58%

VIGL 6.18%

VINC 1.62%

VIR 0.76%

VIRI -1.61%

VIRX 3.33%

VKTX -1.05%

VLON -13.04%

VNDA -2.52%

VOR -2.42%

VRCA 0.50%

VRDN -4.39%

VRNA -1.40%

VRPX 0.38%

VRTX 0.08%

VSTM -3.38%

VTGN -1.81%

VTVT -2.97%

VTYX -0.42%

VXRT -2.67%

VYGR -1.92%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.61%

XBIO 0.93%

XBIT 0.83%

XCUR 3.61%

XENE -3.05%

XERS 1.90%

XFOR 3.73%

XLO 4.43%

XLRN 0.00%

XNCR 0.16%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -9.74%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.19%

ZNTL -2.62%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Sr One Capital Management, Llc	Sell	430 578	Common Stock
2023-11-27	Sr One Capital Management, Llc	Sell	178 585	Common Stock
2023-11-15	Worland Stephen T	Buy	5 979	Common Stock
2023-11-15	Byrnes Michael	Buy	4 524	Common Stock
2023-09-09	Loewy Caroline M	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
28.90
Last 94 transactions
Buy: 4 047 347 \| Sell: 1 063 888

सहसंबंध (AI algo v.1.1b): Undervalued: 0.94% $0.00131 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

eFFECTOR Therapeutics, सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

eFFECTOR Therapeutics, वित्तीय

Annual	2023
राजस्व:	$0
सकल लाभ:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2023
राजस्व:	$0
सकल लाभ:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2022
राजस्व:	$3.55M
सकल लाभ:	$3.50M (98.51 %)
EPS:	$-7.85

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

eFFECTOR Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.